Singapore markets closed

Trevi Therapeutics, Inc. (TRVI)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
3.0200+0.0100 (+0.33%)
At close: 04:00PM EDT
3.0200 0.00 (0.00%)
After hours: 04:02PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
21,696
23,683
19,834
22,984
22,328
Selling general and administrative
9,827
10,240
10,073
9,492
10,161
Total operating expenses
31,523
33,923
29,907
32,476
32,489
Operating income or loss
-31,523
-33,923
-29,907
-32,476
-32,489
Interest expense
1,244
391
1,163
1,202
456
Total other income/expenses net
-94
469
142
-293
-9
Income before tax
-32,189
-29,097
-29,188
-33,961
-32,776
Income tax expense
-22
-32
-36
-21
-18
Income from continuing operations
-32,167
-29,065
-29,152
-33,940
-32,758
Net income
-32,167
-29,065
-29,152
-33,940
-32,758
Net income available to common shareholders
-32,167
-29,065
-29,152
-33,940
-32,758
Basic EPS
-0.22
-
-0.45
-1.49
-1.81
Diluted EPS
-0.22
-
-0.45
-1.49
-1.81
Basic average shares
98,786
-
64,542
22,841
18,059
Diluted average shares
98,786
-
64,542
22,841
18,059